Anti-Inflammation and Chondrogenic Differentiation Effects of Inclusion Nanocomplexes of Hyaluronic Acid-Beta Cyclodextrin and Simvastatin
Overview
Authors
Affiliations
The aim of this study was to prepare inclusion nanocomplexes of hyaluronic acid-β-cyclodextrin and simvastatin (HA-β-CD/SIM) and evaluate anti-inflammation effects on lipopolysaccharide (LPS)-activated synoviocytes and chondrogenic differentiation effects on rat adipose-derived stem cells (rADSCs). The β-CD moieties in HA-β-CD could incorporate SIM to form HA-β-CD/SIM nanocomplexes with diameters of 297-350 nm. HA-β-CD/SIM resulted in long-term release of SIM from the nanocomplexes for up to 63 days in a sustained manner. studies revealed that HA-β-CD/SIM nanocomplexes were able to effectively and dose-dependently suppress the mRNA expression levels of pro-inflammatory markers such as matrix metallopeptidase-3 (MMP-3), MMP-13, cyclooxygenase-2 (COX-2), a disintegrin and metalloproteinase with thrombospondin motifs-5 (ADAMTS-5), interleukin-6 (IL-6), and tumor necrosis factor (TNF-α) in LPS-stimulated synoviocytes. HA-β-CD/SIM-treated rADSCs significantly and dose-dependently enhanced mRNA expressions of aggrecan, collagen type II (COL2A1), and collagen type X (COL10A1), implying that HA-β-CD/SIM greatly induced the chondrogenic differentiation of rADSCs. Conclusively, HA-β-CD/SIM nanocomplexes will be a promising therapeutic material to alleviate inflammation as well as promote chondrogenesis.
Sultan M, Lee O, Lee J, Park C Biomedicines. 2022; 10(12).
PMID: 36551978 PMC: 9775525. DOI: 10.3390/biomedicines10123224.
Recent Advances of Chitosan Formulations in Biomedical Applications.
Abourehab M, Pramanik S, Abdelgawad M, Abualsoud B, Kadi A, Javed Ansari M Int J Mol Sci. 2022; 23(18).
PMID: 36142887 PMC: 9504745. DOI: 10.3390/ijms231810975.
Cui J, Duan M, Sun Q, Fan W World J Microbiol Biotechnol. 2020; 36(4):54.
PMID: 32172435 DOI: 10.1007/s11274-020-02830-5.
Heo J, Noh J, Park S, Ji Y, Ju H, Kim D Pharmaceutics. 2019; 11(9).
PMID: 31480552 PMC: 6781549. DOI: 10.3390/pharmaceutics11090438.